CN Patent

CN103142612B — 一种组合物的医药用途

Assigned to Shenzhen Salubris Pharmaceuticals Co Ltd · Expires 2013-11-13 · 13y expired

What this patent protects

本发明涉及一种药物组合物在治疗呼吸系统疾病方面的用途，该药物组合物对产β-内酰胺酶菌感染引起的对于中、重度慢性支气管炎急性发作患者的治疗效果好于其他中、重度呼吸系统、泌尿系统感染疾病患者。

USPTO Abstract

本发明涉及一种药物组合物在治疗呼吸系统疾病方面的用途，该药物组合物对产β-内酰胺酶菌感染引起的对于中、重度慢性支气管炎急性发作患者的治疗效果好于其他中、重度呼吸系统、泌尿系统感染疾病患者。

Drugs covered by this patent

Patent Metadata

Patent number
CN103142612B
Jurisdiction
CN
Classification
—
Expires
2013-11-13
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Salubris Pharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.